The inclusion of SARS-CoV-2 in the BIOFIRE® RP2.1 panel allows healthcare providers to quickly identify patients with common respiratory pathogens, as well as those with COVID-19, using one ...

The BIOFIRE Respiratory Panel 2.1 plus (RP2.1 plus) tests for 23 pathogens (19 viruses, including SARS-CoV-2, and 4 bacteria) responsible for the most frequent respiratory tract infections.

The BD MAX Respiratory Viral Panel detected and differentiated between influenza A and B respiratory syncytial virus and SARS-CoV-2. The panel requires less than 1.5 minutes hands-on time per sample.

With the addition of the SARS-CoV-2 virus, the panel now includes 19 viral and 2 bacterial targets.

Rather than running multiple tests on samples, the PKamp Respiratory SARS-CoV-2 RT-PCR Panel is designed to conserve resources by testing a single nasopharyngeal, oropharyngeal or nasal swab sample ...

NEWARK, DE / ACCESS Newswire/ February 18, 2025 / The global swab and viral transport medium marketis projected to witness consistent growth over the next decade, reaching approximately USD 9,714. ...

The new BD MAX Respiratory Viral Panel can test for SARS-CoV-2, Influenza A + B and Respiratory Syncytial Virus (RSV) at once.

Vaccines to prevent coronavirus disease 2019 (Covid-19) are urgently needed. The effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines on viral replication in both upper a ...

Importantly, based on viral load distribution in individuals that were tested for the first time in this study, approximately 20% of those infected with SARS-CoV-2 would be missed if sampled using ...

Eurofins Technologies (Paris:ERF) announces the launch of two RT-PCR assays to accurately diagnose respiratory diseases caused by SARS-CoV-2, Influenza virus or RSV.